QualityStocks today announced that a new audio interview with Sohm has been posted online. The interview can be heard at http://qualitystocks.net/interview-shmn.php.
Sohm is a globally recognized pharmaceutical manufacturer that develops, manufactures, and distributes generic, private label, and Sohm-innovated pharmaceutical, cosmeceutical, and nutraceutical products.
R&D activities capitalize on the company’s expertise in numerous drug delivery technologies, including solid dosage form, oral-controlled and sustained releases semi-solid, liquid, oral transmucosal, transdermal, gel, and other drug delivery technologies, as well as the application of these technologies to proprietary drug forms. The company aims to exports these products worldwide, with a focus on distribution in emerging markets such as Africa, Latin America and Southeast Asia.
In the interview, SHMN president and CEO Shailesh Shah details the company’s business model, which is supported by strategic research and development initiatives, as well as several manufacturing facilities.
Mr. Shah also discusses his extensive background in marketing, sales, marketing, business management and other relative areas. Collectively, members of the company’s leadership teams in the U.S. and India have nearly 200 years of pharmaceutical experience.
SHMN had several successes in 2013, including the launch of several products, which Mr. Shah said have been well received in their respective U.S. and India markets. Based on its success, SHMN will continue to expand its product lines and Mr. Shah anticipates 60-70% revenue growth to more than $2 million for 2013, as compared to last year revenue of approx. $1.29 million.
Shailesh Shah concluded the interview by embellishing the numerous applications for the company’s product lines.
For more information, visit www.sohm.com
Let us hear your thoughts: Sohm, Inc. Message Board